期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The role of mRNA splicing in prostate cancer 被引量:3
1
作者 Anna V Lapuk Stanislav V Volik +1 位作者 Yuzhuo Wang Colin C Collins 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第4期515-521,共7页
Alternative splicing (AS) is a crucial step in gene expression. It is subject to intricate regulation, and its deregulation in cancer can lead to a wide array of neoplastic phenotypes. A large body of evidence impli... Alternative splicing (AS) is a crucial step in gene expression. It is subject to intricate regulation, and its deregulation in cancer can lead to a wide array of neoplastic phenotypes. A large body of evidence implicates splice isoforms in most if not all hallmarks of cancer, including growth, apoptosis, invasion and metastasis, angiogenesis, and metabolism. AS has important clinical implications since it can be manipulated therapeutically to treat cancer and represents a mechanism of resistance to therapy. In prostate cancer (PCa) AS also plays a prominent role and this review will summarize the current knowledge of alternatively spliced genes with important functional consequences. We will highlight accumulating evidence on AS of the components of the two critical pathways in PCa: androgen receptor (AR) and phosphoinositide 3-kinase (PI3K). These observations together with data on dysregulation of splice factors in PCa suggest that AR and PI3K pathways may be interconnected with previously unappreciated splicing regulatory networks. In addition, we will discuss several lines of evidence implicating splicing regulation in the development of the castration resistance. 展开更多
关键词 alternative splicing prostate cancer androgen receptor PI3K pathway CRPC neuroendocrine transdifferentiation REST repressor complex
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部